Background Sarcopenia is defined as the loss of skeletal muscle mass and function
associated with aging. Muscle mass can be reliably and accurately quantified using clinical …

Measurements of skeletal muscle cross-sectional area, index, and radiation attenuation
utilizing clinical computed tomography (CT) scans are used in assessments of sarcopenia …

Purpose The progressive loss of skeletal muscle and function (known as sarcopenia) has
been shown to be associated with various adverse outcome measures. Sophisticated …

Objective: Until now, cutoff values of low skeletal muscle mass using computed tomography
(CT) were driven by optimal stratification to predict mortality in cancer patients. The aim of …

Background For the diagnosis of Sarcopenia, European Working Group on Sarcopenia in
Older People (EWGSOP) revised the algorisms in 2019, where they added computed …

Background Opportunistic assessment of sarcopenia on CT examinations is becoming
increasingly common. This study aimed to determine relationships between CT-measured …

Measurements of skeletal muscle cross-sectional area (SMA) at the level of the third lumbar
(L3) vertebra derived from clinical computed tomography (CT) scans are commonly used in …

Sarcopenia encompasses the loss of muscle mass and strength/function during aging.
Several methods are available for the estimation of muscle or lean body mass. Popular …

Background Although computed tomography (CT) is considered the gold standard for
investigating skeletal muscles, diagnostic cutoff points for sarcopenia have not been …

Sarcopenia is defined as the loss of muscle mass or function and has been associated with
increased morbidity and mortality in a variety of diseased populations. Sarcopenia results …